APAC CIOOutlook
About UsConferencePartner With Us
  • Technologies
    • Blockchain
      Data Intelligence and Management
      Digital Transformation
      FinTech
      Generative and Agentic AI
      Low Code No Code
      Mobile Application
      Networking
      Robotics
      Storage
      Wireless
  • Industries
    • Automotive
      Aviation
      Banking
      Construction
      E-Commerce
      Food and Beverages
      Healthcare
      Insurance
      Logistics
      Manufacturing
      Retail
      Supply Chain
      Travel and Hospitality
  • Platforms
    • Microsoft
      Salesforce
      SAP
  • Strategic Solutions
    • Business Intelligence
      Contact Center
      Corporate Finance
      CRM
      Cyber Security
      Data Center
      Enterprise Asset Management
      Enterprise Performance Management
      IT Infrastructure and Services
      Managed Services
      Procurement
      Unified Communication
      Workflow
  • Home
  • CXO Insights
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Whitepapers
  • CXO Awards
#

Apac CIOOutlook Weekly Brief

×

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIOOutlook

Subscribe

loading

THANK YOU FOR SUBSCRIBING

  • Home
  • News

Connect Biopharmaceuticals Secures $55 Million in Series B Round of Financing to Accelerate Clinical Development of Novel Immune Modulators

In addition to the financing, Ms. Jennifer Jin, Partner at Advantech Capital, is expected to join Connect's Board of Directors. 

By

Apac CIOOutlook | Tuesday, August 25, 2020

In addition to the financing, Ms. Jennifer Jin, Partner at Advantech Capital, is expected to join Connect's Board of Directors.

Fremont, CA: Connect Biopharmaceuticals, a clinical-stage company that discovers and develops novel immune modulators for the treatment of autoimmune diseases and inflammation, raised a $55 million Series B financing led by new investor Advantech Capital with active participation by current investors Qiming Venture Partners, Northern Light Venture Capital, and Cowin Venture. CEC Capital acted as the exclusive financial advisor for the financing.

The company intends to use the funds to fund the two ongoing Phase 2 clinical trials of its lead drug candidate CBP-307, a next-generation S1P1 agonist, in patients with ulcerative colitis and Crohn's disease. The funding will also support a planned multiple ascending dose clinical trial of CBP-201, a highly potent IL-4Rα antibody, in patients with atopic dermatitis.

Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.

In addition to the financing, Ms. Jennifer Jin, Partner at Advantech Capital, is expected to join Connect's Board of Directors.

"We are extremely pleased to welcome such a well-recognized healthcare investor who shares our long-term vision of delivering better and innovative medicines to people with serious chronic autoimmune diseases and inflammation, and we are very grateful to our current investors for their continued support," stated Dr.Wubin Pan, Co-founder, President and Chairman of the Board of Directors of Connect. "We are delighted to welcome Jennifer to the Board and we look forward to working closely with her to guide and support the company as it enters an exciting new phase."

"The successful financing speaks to the significant progress the Connect team has made in advancing our product pipeline in the past two years," commented Dr. Zheng Wei, Co-founder and CEO of Connect. "We are very pleased that CBP-307 and CBP-201, two drug candidates discovered internally, continue to rapidly progress in clinical development.

CBP-307 has shown excellent tolerability, pharmacokinetic properties and biomarker activity in Phase 1 and is currently in Phase 2 trials in patients with ulcerative colitis and Crohn's disease. An interim safety review of the first-in-human CBP-201 clinical trial has shown excellent safety and pharmacokinetic profile and supports progression into a multiple ascending dose study in patients with atopic dermatitis. This new funding will support the continuing development of these internally discovered drug candidates in patients with serious diseases and high unmet needs."

See also: Top Change Management Consulting/Service Companies

More in News

The Strategic Value of Strong Supplier Relationships

...Read more

Quantum Technology: Driving APAC Industrial Transformation

Quantum technology is significantly advancing the fields of computation, communication, and sensing, thereby creating opportunities that were previously considered theoretical. Various organizations and research institutions are engaged in competition to develop more reliable qubits, implement effective error correction techniques, and establish scalable systems capable of addressing challenges that surpass the capabilities of classical computers. Emerging practical applications span a range of areas, including the acceleration of drug discovery, enhancement of cybersecurity measures, and optimization of complex logistical operations. Although challenges such as hardware fragility, environmental sensitivity, and substantial development costs remain, ongoing innovations in materials, cooling systems, and quantum algorithms are progressively mitigating these issues. Consequently, quantum technology is a domain where promise and progress are evolving in tandem. How Does Quantum Technology Benefit Industries Today? Quantum technology is starting to deliver real benefits across several industries by solving problems that were previously too complex or time-consuming for classical systems. In pharmaceuticals, quantum simulations are helping researchers model molecular interactions more accurately, speeding up drug discovery and reducing trial-and-error testing. Finance companies are exploring quantum algorithms to optimize portfolios, manage risk, and detect fraud faster than traditional systems. Even logistics and manufacturing are seeing advantages, with quantum-based optimization improving supply chain efficiency and resource allocation in ways that were once impossible at scale. Beyond computational speed, industries are also benefiting from advances in quantum sensing and communication. Quantum sensors offer unprecedented precision in fields like navigation, energy exploration, and environmental monitoring, while quantum encryption promises highly secure communication channels that could transform data security. By integrating these capabilities, businesses can make smarter decisions, reduce costs, and innovate faster. While adoption is still in early stages, the combination of computation, sensing, and secure communication is already giving forward-looking companies a competitive edge, showing that Quantum technology is moving from theory into tangible industry impact. What Innovations Are Shaping the Future of Quantum Technology? The future of Quantum technology is being driven by innovations that make quantum systems more stable, scalable, and practical for real-world use. Advances in qubit design, materials, and error-correction techniques are improving reliability, while hybrid quantum-classical algorithms allow businesses and researchers to harness quantum capabilities even before fully fault-tolerant machines are ready. This is opening early applications in areas like finance, logistics, and healthcare, where complex problems can be solved faster and more accurately than ever before. Moreover, breakthroughs in quantum communication, sensing, and software are expanding its reach. Quantum networks promise ultra-secure data transfer, while quantum sensors deliver unmatched precision in navigation, energy, and environmental monitoring. Cloud-based platforms are also making quantum tools accessible to smaller organizations, democratizing experimentation and innovation. Together, these advancements are positioning Quantum technology as a transformative force that can reshape industries, accelerate scientific discovery, and unlock entirely new possibilities. ...Read more

Mastering PPP project analysis, financing, contracts & transaction management techniques

Infocus International is delighted to bring one of their best virtual workshops,  Public-Private Partnership (PPP)  that will be set to commence  17 August 2026 . We need new infrastructure. Roads, airports, schools, hospitals and housing: the list is enormous and growing. Yet severely limited budgets, economic uncertainty caused by volatile commodity prices, and deficits continue to prevent government at all levels from delivering the kinds of structural change that has always been needed. In response, some countries have developed successful PPP programmes. Merely grasping the concepts of PPP does not do justice to our great responsibility of having an ownership in the country’s future. We already know what we need to do, now is the time to really discover HOW. One of our participants from  Electricity Generation Company (Malawi) Ltd  shared that, “ The facilitator was very knowledgeable on the subject matter, very responsive to questions and innovative in the delivery of the PPP training program. The knowledge gained will assist me in productive participation in ongoing and planned PPP Projects in my country.” Another participant from  PNG Ports Corporation  also mentioned that,  “This is an excellent course for anyone involved in PPP. Highly recommended.” Benefits of Attending • Use best practices from international case studies of successful PPP transactions and common practical pitfalls to avoid • Design and manage PPP legal, regulatory & institutional frameworks to attract investors and complete PPP transactions • Apply models for the efficient design and completion of PPP feasibility studies • Understand project financing requirements and evaluate PPP financial models for both affordability and bankability • Evaluate and apply different credit enhancement techniques to ensure PPP bankability, including blended financing, viability gap funding (VGF), partial guarantees, risk insurance products, output-based aid (OBA) and other financial instruments • Design PPP transaction implementation plans and manage & oversee PPP transaction advisors for reaching commercial closure and financial closure • Models for PPP tender documents, including PPP Project Information Memoranda (“InfoMemos”), Requests for Qualifications (RFQs), Requests for Proposals (RFPs) • International models for designing and drafting PPP contracts & agreements • Environmental & social impact mitigation techniques to structure sustainable private investments in public infrastructure • Plans for managing sustainable PPP contracts including ensuring technical performance, quality of service delivery, price review & adjustment regulatory models, legal contract management and alternative dispute resolution (ADR) techniques Want to learn more? Simply email  media@infocusinternational.com  to register your attendance. For more information, please visit  https://www.infocusinternational.com/ppp-online ...Read more

Deploying Big Data Analysis to Develop IoT Solutions

Data from various sources forms the basic foundation of businesses. In the present times, the improvement of connectivity in the IoT space has resulted in the transfer of huge chunks of data. Therefore, there is a need for big data analytics in IoT in order to address the challenges related to management of large-scale, through the data pipeline architecture. To begin with, data pipeline is the process concerned with the movement of data through an organization. Once data enters into an organization, the stage is referred to as data ingestion. Next in the process is the stage of data transportation from the data ingestion stage to the other stage is known as data collector. Followed by this, the data moves through the processing stage wherein appropriate measures are taken to store it. Data storage stage steps up to the data query stage where it is analyzed through interactive queries. The final stage is concerned with valid presentation of data in different forms of business infographics, such as graphs or statistics. Data generated in the IoT space requires a data management system with the following qualities: •  It should be adapted to manage and process a huge number of data sources, keeping pace with the continuous increase of IoT devices. •  The data management system must have a prompt response time in order to notify the concerned segment of the business in case of failures while processing or storing data. •  The system must be able to scale data on multiple parameters such as a number of devices, storage, and messages. •  Diversity and flexibility are required to process use cases and simultaneously accommodate new use cases. •  The data management system should be cost-effective. All the above criteria suggest that IoT requires interacting with big data analytics tools in order to manage such big chunks of data. ...Read more

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

APAC CIOOutlook
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@apacciooutlook.com
  • sales@apacciooutlook.com
  • marketing@apacciooutlook.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 APAC CIOOutlook. All rights reserved. Headquarteblue in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.apacciooutlook.com/news/connect-biopharmaceuticals-secures-55-million-in-series-b-round-of-financing-to-accelerate-clinical-development-of-novel-immune-modulators-nwid-7692.html